These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33612195)

  • 1. Examining correlates of cannabis users' engagement with a digital intervention for substance use disorder: An observational study of clients in UK services delivering Breaking Free Online.
    Elison-Davies S; Wardell JD; Quilty LC; Ward J; Davies G
    J Subst Abuse Treat; 2021 Apr; 123():108261. PubMed ID: 33612195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a 'telehealth' approach: protocol for a two arm, parallel group randomized controlled trial.
    Elison-Davies S; Pittard L; Myton T; Jones A; Ward J; Davies G
    Addict Sci Clin Pract; 2023 Jun; 18(1):39. PubMed ID: 37269012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Computer-Assisted Therapy for Substance Dependence Using Breaking Free Online: Subgroup Analyses of a Heterogeneous Sample of Service Users.
    Elison S; Davies G; Ward J
    JMIR Ment Health; 2015; 2(2):e13. PubMed ID: 26543918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining effectiveness of tailorable computer-assisted therapy programmes for substance misuse: Programme usage and clinical outcomes data from Breaking Free Online.
    Elison S; Jones A; Ward J; Davies G; Dugdale S
    Addict Behav; 2017 Nov; 74():140-147. PubMed ID: 28645092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between baseline opioid use disorder severity, mental health and biopsychosocial functioning, with clinical responses to computer-assisted therapy treatment.
    Elison-Davies S; Märtens K; Yau C; Davies G; Ward J
    Am J Drug Alcohol Abuse; 2021 May; 47(3):360-372. PubMed ID: 33428458
    [No Abstract]   [Full Text] [Related]  

  • 6. A Web-Based Self-Help Intervention With and Without Chat Counseling to Reduce Cannabis Use in Problematic Cannabis Users: Three-Arm Randomized Controlled Trial.
    Schaub MP; Wenger A; Berg O; Beck T; Stark L; Buehler E; Haug S
    J Med Internet Res; 2015 Oct; 17(10):e232. PubMed ID: 26462848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis.
    Ahlers J; Baumgartner C; Augsburger M; Wenger A; Malischnig D; Boumparis N; Berger T; Stark L; Ebert DD; Haug S; Schaub MP
    J Med Internet Res; 2022 Apr; 24(4):e30138. PubMed ID: 35442196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in child and adult biopsychosocial characteristics associated with regular cannabis use in individuals with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2021 Sep; 226():108887. PubMed ID: 34216859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot trial of a telehealth-delivered behavioral economic intervention promoting cannabis-free activities among adults with cannabis use disorder.
    Coughlin LN; Bonar EE; Wieringa J; Zhang L; Rostker MJ; Augustiniak AN; Goodman GJ; Lin LA
    J Psychiatr Res; 2023 Jul; 163():202-210. PubMed ID: 37224772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between psychosocial risk factors, and changes in substance dependence and psychosocial functioning, during engagement with digital cognitive behavioral therapy for methamphetamine use: use of 'Breaking Free from Substance Abuse' by incarcerated people during the COVID-19 pandemic.
    Elison-Davies S; Newsome J; Jones A; Davies G; Ward J
    Health Justice; 2022 Sep; 10(1):28. PubMed ID: 36070026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Observational Study of a Digital Substance Use and Recovery Program.
    Khan BN; Chu C; Brual J; Dang-Nguyen M; Oladimeji A; Kthupi A; Bolea-Alamañac B; Tadrous M; O'Riordan A; Rubenstein D; Carlin K; Longum P; Gibson D; Abejirinde IO
    Psychiatr Serv; 2024 Jul; ():appips20230427. PubMed ID: 38982834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
    Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
    Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
    Buckner JD; Morris PE; Zvolensky MJ
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-domain correlates of cannabis use disorder severity among young adults.
    Schuster RM; Hareli M; Moser AD; Lowman K; Gilman J; Ulysse C; Schoenfeld D; Evins AE
    Addict Behav; 2019 Jun; 93():212-218. PubMed ID: 30753972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
    Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
    Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
    Mills L; Dunlop A; Montebello M; Copeland J; Bruno R; Jefferies M; Mcgregor I; Lintzeris N
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):67. PubMed ID: 36209081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
    Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of a UK community-based, eTherapy mental health service in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the Full Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.
    Elison S; Ward J; Williams C; Espie C; Davies G; Dugdale S; Ragan K; Chisnall L; Lidbetter N; Smith K
    BMJ Open; 2017 Jul; 7(7):e016392. PubMed ID: 28729322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
    Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.